Lipid implants for controlled release of biotec drugs
The invention is a lipid based implant, produced by screw extrusion. To achieve good extrudability, very homogeneous drug distribution, excellent mechanical strength, sustained release kinetics with a low burst and mainly stable modification of lipids an inventive lipid mixture has to be applied. The mixture is composed of at least 2 lipids, one of them being a high melting, solid lipid and the other a low melting point lipid. Thereby the lipid mixture can contain low
melting lipids in the form of solid, semisold or liquid lipids at room temperature. After adding the drug with a special procedure the mixture is formed into a solid implant by screw extrusion.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…